CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Celltrion, Inc. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2025-00456 filed by Celltrion, Inc. on 2025-01-15. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00456

Filing Date

2025-01-15

Accorded Filing Date

2025-01-15

Institution Decision Date

2025-06-25

Last Modified Date

2025-07-26

Proceeding Type

IPR

Termination Date

2025-06-25

Trial Status

Discretionary Denial

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 16739559
Respondent Patent Number 11084865
Legal Expiration Date
2040-01-10 Active (13.1 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Eric FURFINE et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Discretionary Denial

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Institution Denied 2025-06-25
Director Discretionary Decision: Deny
35 USC 314

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)
Customer Number 191459
Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41408 David Marsh +1 202-942-5068
48001 Thomas Triolo +1 914-847-1612
48921 Stephen Gaudet +1 914-847-7376
50370 Neil Miyamoto +1 914-847-7175
50437 Frank Cottingham +1 914-593-1116
58583 Brian Cocca +1 914-847-1421
58714 Ilona Gont +1 914-847-1304
59668 Brandon Schurter +1 914-847-7000

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 2 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 6 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (8 found):
PTAB: 6 U.S. Courts: 2
USPTO PTAB Trial 2025-07-14
IPR2025-01268

Fresenius Kabi SwissBioSim GmbH et al. v. Regeneron Pharmaceuticals, Inc.

Asserted Patent
Status: Discretionary Denial
USPTO PTAB Trial 2024-12-02
IPR2025-00233

Formycon AG v. Regeneron Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2024-11-20
IPR2025-00176

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2023-08-18
IPR2023-01312

Samsung Bioepis Co., Ltd. v. REGENERON PHARMACEUTICALS, INC.

U.S. Continuation Sibling (10464992)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-01-17
IPR2023-00462

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10464992)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2021-01-07
IPR2021-00402

Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10464992)
Status: Terminated
U.S. District Court 2024-05-17
1:24-cv-00053

Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.

Asserted Patent
Status: WVND
U.S. District Court 2023-11-21
1:23-cv-00094

Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.

Asserted Patent
Status: WVND
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

97
14

Director Discretionary Decision: Deny RESPONSE

2025-06-25 FILING PARTY: BOARD
13

Patent Ownerโ€™s Surreply in Support of Preliminary Patent Owner Response OTHER

2025-06-03 FILING PARTY: PATENT OWNER
2022

Celltrionโ€™s Motion to Dismiss for Lack of Personal Jurisdiction, or Alternatively, to Transfer Venue, 23-cv-89, Dkt. 68 (N.D.W. Va. Jan. 17, 2024) Exhibit

2025-06-03 FILING PARTY: PATENT OWNER
12

Petitionerโ€™s Surreply to Patent Ownerโ€™s Discretionary Denial Reply OTHER

2025-05-30 FILING PARTY: PETITIONER
11

Petitioner's Reply to Patent Owner Preliminary Response OTHER

2025-05-27 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc